Englander Institute for Precision Medicine

Publications

Found 887 results
Author Title Type [ Year(Asc)]
2025
Agarwal PK, Sternberg CN.  2025.  Clinical trials corner issue 11(1).. Bladder Cancer. 11(1):23523735241309418.
Nauseef JT, Chu TR, Hooper WF, Alonso A, Oku A, Geiger H, Goldstein ZR, Shah M, Sigouros M, Manohar J et al..  2025.  A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.. NPJ Precis Oncol. 9(1):91.
Müller-Dott S, Jaehnig EJ, Munchic KPham, Jiang W, Yaron-Barir TM, Savage SR, Garrido-Rodriguez M, Johnson JL, Lussana A, Petsalaki E et al..  2025.  Comprehensive evaluation of phosphoproteomic-based kinase activity inference.. Nat Commun. 16(1):4771.
Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K et al..  2025.  Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.. Commun Med (Lond). 5(1):11.
Chew SMei, Teumer A, Matías-García PR, Gieger C, Winckelmann J, Suhre K, Herder C, Rathmann W, Peters A, Waldenberger M.  2025.  Cross-sectional and longitudinal association of seven DNAm-based predictors with metabolic syndrome and type 2 diabetes.. Clin Epigenetics. 17(1):58.
Jiang W, Jaehnig EJ, Liao Y, Shi Z, Yaron-Barir TM, Johnson JL, Cantley LC, Zhang B.  2025.  Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites.. Nat Commun. 16(1):2766.
Kim YE, Dobko M, Li H, Shao T, Periyakoil P, Tipton C, Colasacco C, Serpedin A, Elemento O, Sabuncu M et al..  2025.  A Deep-Learning Model for Multi-class Audio Classification of Vocal Fold Pathologies in Office Stroboscopy.. Laryngoscope.
Wong EWP, Sahin M, Yang R, Lee UJ, Li D, Zhan YA, Misra R, Tomas F, Alomran N, Polyzos A et al..  2025.  Disruption of TAD hierarchy promotes LTR co-option in cancer.. Nat Genet.
Sternberg CN, Hussain M.  2025.  Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer? Transl Cancer Res. 14(5):2536-2538.
Nepali PR, Gonzalez-Kozlova E, Anegondi M, Dogra N, Archer M, Chakraborty G, Tewari AK, Hopkins BD, Kyprianou N.  2025.  Effect of TGF-β mediated phenotypic changes on prostate cancer cell anoikis response.. Oncogene.
Kocher T, Baumeister S-E, Völzke H, Nauck M, Meisel P, Suhre K, Völker U, Friedrich N, Holtfreter B.  2025.  Elevated Salivary Theobromine and Long-Term Improvement of Periodontal Health in Two Cohort Studies.. J Clin Periodontol.
Tian Y, Bhattacharya R, Yoo S, Jiang F, Park E, Granados GLara, Shen Y, Park K-S, Kaniskan HUmit, Jin J et al..  2025.  Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma.. iScience. 28(5):112387.
Cheng APellan, Widman AJ, Arora A, Rusinek I, Sossin A, Rajagopalan S, Midler N, Hooper WF, Murray RM, Halmos D et al..  2025.  Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling.. Nat Methods.
Sternberg CN, Squifflet P, Saad ED, Burdett S, Fisher D, Kurt M, Teitsson S, May JR, Patel MY, Stoeckle M et al..  2025.  Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy.. Urol Oncol.
Sternberg CN, Squires P, Song Y, Wu A, Gao Y, Kataria RS, Li H.  2025.  Evaluation of Event-Free Survival as a Surrogate Endpoint for Overall Survival in Muscle-Invasive Bladder Cancer Following Neoadjuvant Treatment: A Systematic Review and Meta-Analysis.. Oncol Ther.
Rizzo A, Mozgai S, Sigaras A, Rubin JE, Jotwani R.  2025.  Expert Consensus Best Practices for the Safe, Ethical, and Effective Design and Implementation of Artificially Intelligent Conversational Agent (i.e., Chatbot/Virtual Human) Systems in Health Care Applications.. J Med Ext Real. 2(1):209-222.
Montalvo N, Requena F, Capriotti E, Rausell A.  2025.  Federated Learning for the pathogenicity annotation of genetic variants in multi-site clinical settings.. Bioinformatics.
de Bono JS, He M, Shi Z, Nowicka M, Bracarda S, Sternberg CN, Chi KN, Olmos D, Sandhu S, Massard C et al..  2025.  Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial.. Eur Urol.
Rajendran S, Rehani E, Phu W, Zhan Q, Malmsten JE, Meseguer M, Miller KA, Rosenwaks Z, Elemento O, Zaninovic N et al..  2025.  A foundational model for in vitro fertilization trained on 18 million time-lapse images.. Nat Commun. 16(1):6235.
Claridge SE, Nath S, Baum A, Farias R, Cavallo J-A, Rizvi NM, De Boni L, Park E, Granados GLara, Hauesgen M et al..  2025.  Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer.. Clin Transl Med. 15(2):e70078.
Umesh A, Cordogan S, Simpson SK, Bram JT, Jones RH, Schairer WW, Sboner A, Elemento O, Green DW, Fabricant PD.  2025.  Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study.. Clin Orthop Relat Res.
Suhre K, Chen Q, Halama A, Mendez K, Dahlin A, Stephan N, Thareja G, Sarwath H, Guturu H, Dwaraka VB et al..  2025.  A genome-wide association study of mass spectrometry proteomics using a nanoparticle enrichment platform.. Nat Genet.
Borea R, Reduzzi C.  2025.  The growing field of liquid biopsy and its Snowball effect on reshaping cancer management.. J Liq Biopsy. 8:100293.
Petroni G, Galassi C, Gouin KH, Chen H-H, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G et al..  2025.  IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.. Nat Cancer.
Ge J, Han S, Shi M, Harada M, Yu S, Zheng J, Prehn C, Adamski J, Kastenmüller G, Schlesinger S et al..  2025.  Integrative Metabolomics of Targeted and Non-Targeted Analyses in T2D Progression.. Diabetes Care.